John Voyta
Senior Scientific Fellow, Chair of Ancera's Science Advisory Board at Ancera- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Alison Sparks
John has been a valued colleague over 20+ years. We worked together to develop ultrasensitive chemiluminescent applications in the Tropix start-up environment, and continued technology development to meet shifts in market needs under Applied Biosystems. As Tropix co-founder and Director of Protein Chemistry & Immunology, John drove product introduction, and built the business by interfacing with customers for smooth adoption of chemiluminescence technology in their platforms; these customers still maintain a strong collaborative relationship with the Tropix product team. Upon Tropix acquisition by Applied Biosystems, John’s talents and life science knowledge broadened, as he worked across sites, and through corporate headquarters to combine core technologies in new products. His ability to recognize the value of emerging technologies, and his vision on how to assimilate them in relevant applications forged a close working relationship with Corporate Businesss Development, that contributed to long term R&D planning. During John’s tenure as Scientific Advisory Committee Fellow, he garnered executive support for a focused evaluation and business strategy proposal to offer a stem cell product portfolio. After the acquisition of Ambion, John was given the responsibility for integrating R&D/Product Development, and aligning efforts across 4 groups with overall company strategy. The continued success of Ambion products, as well as their strong cross-site development efforts, speak to his leadership at preserving and promoting their innovative culture in the larger parent company.
Dan Kephart
John was brought in to manage the Ambion site during the integration with Applied Biosystems. John understood the cultural, proceedural, and developmental challenges that Ambion would face and focused on successfully transitioning our operations to become a fully integrated part of Applied Biosystems. He was adept at identifying the critical needs of the site and focused on skills such as budget planning, talent review, and networking within the larger organization. In addition to his technical expertise, he is well organized, can motivate people, and has a great understanding of the challenges faced in large-scale organizational integrations. He is a critical thinker and a direct communicator, and would be a great asset to organizations of any size looking for techincal, operational, or integration guidance.
Alison Sparks
John has been a valued colleague over 20+ years. We worked together to develop ultrasensitive chemiluminescent applications in the Tropix start-up environment, and continued technology development to meet shifts in market needs under Applied Biosystems. As Tropix co-founder and Director of Protein Chemistry & Immunology, John drove product introduction, and built the business by interfacing with customers for smooth adoption of chemiluminescence technology in their platforms; these customers still maintain a strong collaborative relationship with the Tropix product team. Upon Tropix acquisition by Applied Biosystems, John’s talents and life science knowledge broadened, as he worked across sites, and through corporate headquarters to combine core technologies in new products. His ability to recognize the value of emerging technologies, and his vision on how to assimilate them in relevant applications forged a close working relationship with Corporate Businesss Development, that contributed to long term R&D planning. During John’s tenure as Scientific Advisory Committee Fellow, he garnered executive support for a focused evaluation and business strategy proposal to offer a stem cell product portfolio. After the acquisition of Ambion, John was given the responsibility for integrating R&D/Product Development, and aligning efforts across 4 groups with overall company strategy. The continued success of Ambion products, as well as their strong cross-site development efforts, speak to his leadership at preserving and promoting their innovative culture in the larger parent company.
Dan Kephart
John was brought in to manage the Ambion site during the integration with Applied Biosystems. John understood the cultural, proceedural, and developmental challenges that Ambion would face and focused on successfully transitioning our operations to become a fully integrated part of Applied Biosystems. He was adept at identifying the critical needs of the site and focused on skills such as budget planning, talent review, and networking within the larger organization. In addition to his technical expertise, he is well organized, can motivate people, and has a great understanding of the challenges faced in large-scale organizational integrations. He is a critical thinker and a direct communicator, and would be a great asset to organizations of any size looking for techincal, operational, or integration guidance.
Alison Sparks
John has been a valued colleague over 20+ years. We worked together to develop ultrasensitive chemiluminescent applications in the Tropix start-up environment, and continued technology development to meet shifts in market needs under Applied Biosystems. As Tropix co-founder and Director of Protein Chemistry & Immunology, John drove product introduction, and built the business by interfacing with customers for smooth adoption of chemiluminescence technology in their platforms; these customers still maintain a strong collaborative relationship with the Tropix product team. Upon Tropix acquisition by Applied Biosystems, John’s talents and life science knowledge broadened, as he worked across sites, and through corporate headquarters to combine core technologies in new products. His ability to recognize the value of emerging technologies, and his vision on how to assimilate them in relevant applications forged a close working relationship with Corporate Businesss Development, that contributed to long term R&D planning. During John’s tenure as Scientific Advisory Committee Fellow, he garnered executive support for a focused evaluation and business strategy proposal to offer a stem cell product portfolio. After the acquisition of Ambion, John was given the responsibility for integrating R&D/Product Development, and aligning efforts across 4 groups with overall company strategy. The continued success of Ambion products, as well as their strong cross-site development efforts, speak to his leadership at preserving and promoting their innovative culture in the larger parent company.
Dan Kephart
John was brought in to manage the Ambion site during the integration with Applied Biosystems. John understood the cultural, proceedural, and developmental challenges that Ambion would face and focused on successfully transitioning our operations to become a fully integrated part of Applied Biosystems. He was adept at identifying the critical needs of the site and focused on skills such as budget planning, talent review, and networking within the larger organization. In addition to his technical expertise, he is well organized, can motivate people, and has a great understanding of the challenges faced in large-scale organizational integrations. He is a critical thinker and a direct communicator, and would be a great asset to organizations of any size looking for techincal, operational, or integration guidance.
Alison Sparks
John has been a valued colleague over 20+ years. We worked together to develop ultrasensitive chemiluminescent applications in the Tropix start-up environment, and continued technology development to meet shifts in market needs under Applied Biosystems. As Tropix co-founder and Director of Protein Chemistry & Immunology, John drove product introduction, and built the business by interfacing with customers for smooth adoption of chemiluminescence technology in their platforms; these customers still maintain a strong collaborative relationship with the Tropix product team. Upon Tropix acquisition by Applied Biosystems, John’s talents and life science knowledge broadened, as he worked across sites, and through corporate headquarters to combine core technologies in new products. His ability to recognize the value of emerging technologies, and his vision on how to assimilate them in relevant applications forged a close working relationship with Corporate Businesss Development, that contributed to long term R&D planning. During John’s tenure as Scientific Advisory Committee Fellow, he garnered executive support for a focused evaluation and business strategy proposal to offer a stem cell product portfolio. After the acquisition of Ambion, John was given the responsibility for integrating R&D/Product Development, and aligning efforts across 4 groups with overall company strategy. The continued success of Ambion products, as well as their strong cross-site development efforts, speak to his leadership at preserving and promoting their innovative culture in the larger parent company.
Dan Kephart
John was brought in to manage the Ambion site during the integration with Applied Biosystems. John understood the cultural, proceedural, and developmental challenges that Ambion would face and focused on successfully transitioning our operations to become a fully integrated part of Applied Biosystems. He was adept at identifying the critical needs of the site and focused on skills such as budget planning, talent review, and networking within the larger organization. In addition to his technical expertise, he is well organized, can motivate people, and has a great understanding of the challenges faced in large-scale organizational integrations. He is a critical thinker and a direct communicator, and would be a great asset to organizations of any size looking for techincal, operational, or integration guidance.
Experience
-
Ancera
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Senior Scientific Fellow, Chair of Ancera's Science Advisory Board
-
Oct 2021 - Present
-
-
Vice President R&D
-
Jan 2020 - Sep 2021
-
-
Vice President, Biology R&D
-
Jul 2015 - Dec 2019
-
-
Consultant
-
Jul 2015 - Dec 2015
Providing product development guidance as it relates to their novel food testing platform.
-
-
-
Alacrita LLP
-
United Kingdom
-
Associate
-
Nov 2012 - Oct 2017
-
-
-
-
Founder and Principal
-
Jan 2010 - Jan 2016
Providing guidance to life science tools and next generation diagnostics research and development efforts. Providing guidance to life science tools and next generation diagnostics research and development efforts.
-
-
-
Digilab, Inc
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Chief Scientific Officer, Consulting
-
Jan 2014 - Jul 2014
Prepared strategic presentations and business plans for potential investors and distributors highlighting key Digilab products and their applications. Evaluated product portfolio and made recommendations as to product refinements. Prepared strategic presentations and business plans for potential investors and distributors highlighting key Digilab products and their applications. Evaluated product portfolio and made recommendations as to product refinements.
-
-
-
-
Co-founder and Chief Technology Officer
-
Aug 2011 - Dec 2012
-
-
-
Life Technologies
-
United States
-
Biotechnology Research
-
700 & Above Employee
-
Distinguished Scientific Fellow
-
Dec 2008 - Jul 2009
Global R&D, Emerging Technologies-Cell Biology Global R&D, Emerging Technologies-Cell Biology
-
-
-
-
Distinguished Scientific Fellow, VP R&D
-
May 2007 - Nov 2008
Responsible for Molecular and Cell Biology Consumables R&D: Bedford Cell Biology R&D and Austin R&D (Ambion). Drove integration of Ambion R&D into the Applied Biosystems culture.
-
-
Scientific Fellow, Senior Director R&D
-
2004 - 2008
Responsible for Tropix R&D (Bedford), Cellular Detection Systems (CDS) R&D (Bedford), 2004 to 2008; and RNAi R&D (Austin/Ambion), April 2007 to 2008.
-
-
Scientific Fellow, Cell Biology
-
2000 - 2004
Technology Platforms R&D; member of the S&T organization, the Science Organization and then the ART group
-
-
-
PE Biosystems
-
Spain
-
Director, Scientific Operations
-
1996 - 2000
Director Protein Chemistry and Immunology (1986-1999) and Director of Scientific Operations (1999-2000); responsible for Tropix product development, 1986 to 2000 Director Protein Chemistry and Immunology (1986-1999) and Director of Scientific Operations (1999-2000); responsible for Tropix product development, 1986 to 2000
-
-
-
Tropix, Inc.
-
United States
-
Restaurants
-
Director Protein Chemistry and Immunology
-
1986 - 1996
Co-founder of Tropix; responsible for demonstrating utility of the Tropix chemiluminescence technology and product development. Co-founder of Tropix; responsible for demonstrating utility of the Tropix chemiluminescence technology and product development.
-
-
-
Children's Hospital Boston
-
United States
-
Truck Transportation
-
Post-Doctoral Fellow
-
1982 - 1985
Worked with Bruce Zetter, Surgical Research Department: tumor angiogenesis; cell biology of endothelial cells. Worked with Bruce Zetter, Surgical Research Department: tumor angiogenesis; cell biology of endothelial cells.
-
-
Education
-
Baylor College of Medicine
Ph.D., Biochemistry -
The George Washington University School of Medicine and Health Sciences
MS, Biochemistry -
University of Massachusetts, Amherst
BS, Biochemistry
Community
